Unicycive Therapeutics Inc (UNCY) Price Prediction & ForecastUNCYUnicycive Therapeutics Inc

Alphio's UNCY stock price prediction model matches the current Unicycive Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.61 (+3.60%). The 1-week path is $3.49 (+0.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Unicycive Therapeutics Inc is currently not a strong buy due to its recent performance and technical indicators. The current price is $3.49, which is significantly below its 52-week high of $8.74, indicating a potential for recovery but also substantial risk. The RSI is at 32.171, suggesting the stock is oversold, but the recent 5-day change is -2.51%, reflecting continued downward pressure. The forward P/E ratio is 2.0661, which could indicate potential value, but the company has a negative net income and gross profit in recent quarters, with a net income of -21,525,000 USD in Q4 2024 and -6,447,000 USD in Q2 2025. The main risk is the ongoing FDA issues, as highlighted by the recent news of executives being sued for failing to ensure compliance, which could further impact stock performance.

Unicycive Therapeutics Inc (UNCY) last closed at $3.48, losing -7.20%. These facts feed the 1-day and 1-week UNCY price prediction above.